Position in ABBV
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$48,063
+$6,523 QoQ
Shares Held
191
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#4,075
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Hartford Financial Management Inc. holds $6,345,354 across 10 Drug Manufacturers - General names. ABBV ranks #6 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
9,405 | $2,388,587 | |
| 2 | MRK |
Merck & Co., Inc.
|
15,754 | $2,024,389 | |
| 3 | LLY |
ELI LILLY & Co
|
894 | $1,072,290 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
10,183 | $586,744 | |
| 5 | PFE |
Pfizer Inc
|
6,429 | $154,810 | |
| 6 | ABBV |
AbbVie Inc.
This page
|
191 | $48,063 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
289 | $36,512 | |
| 8 | AMGN |
Amgen Inc
|
80 | $28,969 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $48,063 | 191 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $41,540 | 191 | Shares | Sole | 2026-04-16 | |
| 2025-12-31 | $43,641 | 191 | Shares | Sole | 2026-01-21 | |
| 2025-09-30 | $44,224 | 191 | Shares | Sole | 2025-10-28 | |
| 2025-06-30 | $35,453 | 191 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $5,278,018 | 25,191 | Shares | Sole | 2025-04-21 | |
| 2024-12-31 | $4,476,440 | 25,191 | Shares | Sole | 2025-01-23 | |
| 2024-09-30 | $4,937,000 | 25,000 | Shares | Sole | 2024-10-28 | |
| 2024-06-30 | $4,288,000 | 25,000 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $4,570,710 | 25,100 | Shares | Sole | 2024-04-24 | |
| 2023-12-31 | $3,889,747 | 25,100 | Shares | Sole | 2024-01-29 | |
| 2023-09-30 | $3,741,406 | 25,100 | Shares | Sole | 2023-10-24 | |
| 2023-06-30 | $3,381,723 | 25,100 | Shares | Sole | 2023-07-27 | |
| 2023-03-31 | $4,000,187 | 25,100 | Shares | Sole | 2023-04-25 | |
| 2022-12-31 | $4,056,411 | 25,100 | Shares | Sole | 2023-02-01 | |
| 2022-09-30 | $3,368,671 | 25,100 | Shares | Sole | 2022-10-25 | |
| 2022-06-30 | $3,844,316 | 25,100 | Shares | Sole | 2022-07-21 | |
| 2022-03-31 | $4,068,961 | 25,100 | Shares | Sole | 2022-05-05 | |
| 2021-12-31 | $3,385,000 | 25,000 | Shares | Sole | 2022-01-27 | |
| 2021-09-30 | $2,707,213 | 25,097 | Shares | Sole | 2021-10-29 | |
| 2021-06-30 | $2,816,000 | 25,000 | Shares | Sole | 2021-07-27 | |
| 2021-03-31 | $2,705,500 | 25,000 | Shares | Sole | 2021-04-14 | |
| 2020-12-31 | $2,143,000 | 20,000 | Shares | Sole | 2021-02-03 | |
| 2020-09-30 | $1,751,800 | 20,000 | Shares | Sole | 2020-10-16 | |
| 2020-06-30 | $1,963,600 | 20,000 | Shares | Sole | 2020-07-23 | |
| 2020-03-31 | $1,523,800 | 20,000 | Shares | Sole | 2020-05-01 | |
| No filing history on record for this holder in this stock. | ||||||